With Simon-Kucher & Partners’ life sciences division
China’s Trial Advantage: Tracking Nation’s Growth in Pharma Innovation and Global Investment
A look at China's emergence as a hub for novel treatment pursuits—and ways international investors can best capitalize on the favorable research trajectory.